{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:59:49Z","timestamp":1790629189850,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41433-019-0731-5","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T15:04:09Z","timestamp":1576508649000},"page":"279-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Fibrosis in dysthyroid eye disease"],"prefix":"10.1038","volume":"34","author":[{"given":"Marian","family":"Ludgate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"731_CR1","doi-asserted-by":"publisher","unstructured":"Perros P, Heged\u00fcs L, Bartalena L, Marcocci C, Kahaly GJ, Baldeschi L, et al. Graves\u2019 orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement. Orphanet J Rare Dis. 2017;12:72. https:\/\/doi.org\/10.1186\/s13023-017-0625-1.","DOI":"10.1186\/s13023-017-0625-1"},{"issue":"4","key":"731_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/17469899.2016.1202113","volume":"11","author":"Mohd Shazli Draman","year":"2016","unstructured":"Draman MS, Ludgate M. Thyroid eye disease an update. Expert Rev Ophthalmol. 2016. https:\/\/doi.org\/10.1080\/17469899.2016.1202113.","journal-title":"Expert Review of Ophthalmology"},{"key":"731_CR3","doi-asserted-by":"publisher","first-page":"249125","DOI":"10.1155\/2015\/249125.","volume":"2015","author":"J Barrio-Barrio","year":"2015","unstructured":"Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Velazquez-Villoria A, Galofre JC. Graves\u2019 Ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. J Ophthalmol. 2015;2015:249125 https:\/\/doi.org\/10.1155\/2015\/249125.","journal-title":"J Ophthalmol"},{"key":"731_CR4","doi-asserted-by":"crossref","unstructured":"Wiersinga WM, Kahaly GJ. Graves\u2019 orbitopathy: a multidisciplinary approach. 3rd ed. Karger; Basel; 2017.","DOI":"10.1159\/isbn.978-3-318-06085-0"},{"key":"731_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/bjo.82.7.773","volume":"82","author":"CB Terwee","year":"1998","unstructured":"Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM. Development of a disease specific quality of life questionnaire for patients with Graves\u2019 ophthalmopathy: the GO-QOL. Br J Ophthalmol. 1998;82:773\u20139.","journal-title":"Br J Ophthalmol"},{"key":"731_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/cen.12222.","volume":"79","author":"WM Wiersinga","year":"2013","unstructured":"Wiersinga WM. Smoking and thyroid. Clin Endocrinol. 2013;79:145\u201351. https:\/\/doi.org\/10.1111\/cen.12222.","journal-title":"Clin Endocrinol"},{"key":"731_CR7","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS. Graves\u2019 ophthalmopathy. N Engl J Med. 2010;362:726\u201338. https:\/\/doi.org\/10.1056\/NEJMra0905750.","journal-title":"N Engl J Med"},{"issue":"6","key":"731_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/jamaophthalmol.2018.0806","volume":"136","author":"Giovanna Rotondo Dottore","year":"2018","unstructured":"Rotondo Dottore G, Torregrossa L, Caturegli PP, Ionni I, Sframeli A, Sabini E, et al. Association of T and B cells infiltrating orbital tissues with clinical features of Graves\u2019 orbitopathy. JAMA Ophthalmol. 2018;136:613\u20139. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.0806.","journal-title":"JAMA Ophthalmology"},{"key":"731_CR9","doi-asserted-by":"publisher","first-page":"E400","DOI":"10.1210\/jc.2011-2697.","volume":"97","author":"S Virakul","year":"2012","unstructured":"Virakul S, van Steensel L, Dalm VA, Paridaens D, van Hagen PM, Dik WA. Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves\u2019 ophthalmopathy. J Clin Endocrinol Metab. 2012;97:E400\u2013408. https:\/\/doi.org\/10.1210\/jc.2011-2697.","journal-title":"J Clin Endocrinol Metab"},{"key":"731_CR10","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJM199712043372307","volume":"337","author":"R Paschke","year":"1997","unstructured":"Paschke R, Ludgate M. The thyrotropin receptor in thyroid disease. N Engl J Med. 1997;337:1675\u201381.","journal-title":"N Engl J Med"},{"key":"731_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1530\/acta.0.1200473","volume":"120","author":"C Marcocci","year":"1989","unstructured":"Marcocci C, Bartalena L, Bogazzi F, Panicucci M, Pinchera A. Studies on the occurrence of ophthalmopathy in Graves\u2019 disease. Acta Endocrinol. 1989;120:473\u20138.","journal-title":"Acta Endocrinol"},{"key":"731_CR12","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1210\/jcem.87.4.8411","volume":"87","author":"R Metcalfe","year":"2002","unstructured":"Metcalfe R, Jordan N, Watson P, Gullu S, Wiltshire M, Crisp M, et al. Demonstration of IgG, IgA and IgE autoantibodies to the human thyrotropin receptor using flow cytometry. J Clin Endocrinol Metab. 2002;87:1754\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"731_CR13","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1210\/jcem.82.6.2003","volume":"82","author":"M Crisp","year":"1997","unstructured":"Crisp M, Lane C, Halliwell M, Wynford-Thomas D, Ludgate M. Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab. 1997;82:2003\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"731_CR14","doi-asserted-by":"crossref","unstructured":"Starkey KJ, Heufelder A, Baker G, Joba W, Evans M, Davies S, et al. Adipose thyrotrophin receptor expression is elevated in Graves\u2019 and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol. 2003;30:369\u201380.","DOI":"10.1677\/jme.0.0300369"},{"key":"731_CR15","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1210\/jc.2005-2813","volume":"91","author":"A Eckstein","year":"2006","unstructured":"Eckstein A, Plicht M, Lax H, Neuha\u0308user M, Mann K, Lederbogen S, et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 opthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab. 2006;91:3464\u201370. https:\/\/doi.org\/10.1210\/jc.2005-2813","journal-title":"J Clin Endocrinol Metab"},{"key":"731_CR16","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1210\/en.2013-1576.","volume":"154","author":"S Moshkelgosha","year":"2013","unstructured":"Moshkelgosha S, So PW, Deasy N, Diaz-Cano S, Banga JP. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves\u2019 orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation. Endocrinology. 2013;154:3008\u201315. https:\/\/doi.org\/10.1210\/en.2013-1576.","journal-title":"Endocrinology"},{"issue":"4","key":"731_CR17","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1210\/en.2015-1829","volume":"157","author":"Utta Berchner-Pfannschmidt","year":"2016","unstructured":"Berchner-Pfannschmidt U, Moshkelgosha S, Diaz-Cano S, Edelmann B, G\u00f6rtz G-E, Horstmann M, et al. Comparative assessment of female mouse model of Graves\u2019 orbitopathy under different environments, accompanied by proinflammatory cytokine and T-cell responses to thyrotropin hormone receptor antigen. Endocrinology. 2016;157:1673\u201382. https:\/\/doi.org\/10.1210\/en.2015-1829.","journal-title":"Endocrinology"},{"issue":"1","key":"731_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1210\/er.2018-00066","volume":"40","author":"Terry J Smith","year":"2018","unstructured":"Smith TJ, Janssen J. Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy. Endocr Rev. 2018; https:\/\/doi.org\/10.1210\/er.2018-00066.","journal-title":"Endocrine Reviews"},{"key":"731_CR19","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1210\/jc.2012-1771.","volume":"98","author":"WB Minich","year":"2013","unstructured":"Minich WB, Dehina N, Welsink T, Schwiebert C, Morgenthaler NG, K\u00f6hrle J, et al. Autoantibodies to the IGF1 receptor in Graves\u2019 orbitopathy. J Clin Endocrinol Metab. 2013;98:752\u201360. https:\/\/doi.org\/10.1210\/jc.2012-1771.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"731_CR20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s40618-018-0943-8","volume":"42","author":"M. Marin\u00f2","year":"2018","unstructured":"Marino M, Rotondo Dottore G, Ionni I, Lanzolla G, Sabini E, Ricci D, et al. Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves\u2019 disease and Graves\u2019 orbitopathy. J Endocrinol Investig. 2019;42:471\u201380. https:\/\/doi.org\/10.1007\/s40618-018-0943-8.","journal-title":"Journal of Endocrinological Investigation"},{"key":"731_CR21","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1210\/jc.2014-3566","volume":"100","author":"CC Krieger","year":"2015","unstructured":"Krieger CC, Neumann S, Place RF, Marcus-Samuels B, Gershengorn MC. Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves\u2019 disease immunoglobins. J Clin Endocrinol Metab. 2015;100:1071\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"731_CR22","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMoa1614949.","volume":"376","author":"TJ Smith","year":"2007","unstructured":"Smith TJ, George J, Kahaly MD, Daniel G, Ezra MD, James C, et al. Teprotumumab for thyroid-associated ophthalmopathy. N Engl J Med. 2007;376:1748\u201361. https:\/\/doi.org\/10.1056\/NEJMoa1614949.","journal-title":"N Engl J Med"},{"key":"731_CR23","unstructured":"Taylor P, Zhang L, Lee R, Muller I, Ezra D, Dayan M, et al. New Insights into the pathogenesis and non-surgical management of Graves\u2019 orbitopathy. Nat Rev Endocrinol. Accepted for publication."},{"key":"731_CR24","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1167\/iovs.15-16580.","volume":"56","author":"K Kozdon","year":"2015","unstructured":"Kozdon K, Fitchett C, Rose GE, Ezra DG, Bailly M. Mesenchymal stem cell-like properties of orbital fibroblasts in Graves\u2019 orbitopathy. Investig Ophthalmol Vis Sci. 2015;56:5743\u201350. https:\/\/doi.org\/10.1167\/iovs.15-16580.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"11","key":"731_CR25","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1167\/iovs.15-16610","volume":"56","author":"Sven Brandau","year":"2015","unstructured":"Brandau S, Bruderek K, Hestermann K, G\u00f6rtz GE, Horstmann M, Mattheis S, et al. Orbital fibroblasts from Graves\u2019 orbitopathy patients share functional and immunophenotypic properties with mesenchymal stem\/stromal. Cells Investig Ophthalmol Vis Sci. 2015;56:6549\u201357. https:\/\/doi.org\/10.1167\/iovs.15-16610.","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"731_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2249.2005.02824.x.","volume":"141","author":"TJ Smith","year":"2005","unstructured":"Smith TJ. Insights into the role of fibroblasts in human autoimmune diseases. Clin Exp Immunol. 2005;141:388\u201397. https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02824.x.","journal-title":"Clin Exp Immunol"},{"key":"731_CR27","doi-asserted-by":"publisher","first-page":"E3451","DOI":"10.1073\/pnas.1506113113.","volume":"113","author":"E Alonso-Merino","year":"2016","unstructured":"Alonso-Merino E, Mart\u00edn-Orozco R, Ru\u00edz-Llorente L, Mart\u00ednez-Iglesias O, Velasco-Mart\u00edn J, Montero-Pedrazuela A, et al. Thyroid hormones inhibit TGF-\u03b2 signaling and attenuate fibrotic responses. PNAS. 2016;113:E3451\u2013E3460. https:\/\/doi.org\/10.1073\/pnas.1506113113.","journal-title":"PNAS"},{"issue":"12","key":"731_CR28","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1167\/iovs.06-0596","volume":"47","author":"Lei Zhang","year":"2006","unstructured":"Zhang L, Baker G, Janus D, Paddon C, Fuhrer D, Ludgate M. Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Investig Ophthalmol Vis Sci. 2006;47:5197\u2013203. https:\/\/doi.org\/10.1167\/iovs.06-0596.","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"731_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/jme-11-0006.","volume":"46","author":"S Kumar","year":"2011","unstructured":"Kumar S, Nadeem S, Stan MN, Coenen M, Bahn RS. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves\u2019 ophthalmopathy. J Mol Endocrinol. 2011;46:155\u201363. https:\/\/doi.org\/10.1530\/jme-11-0006.","journal-title":"J Mol Endocrinol"},{"key":"731_CR30","doi-asserted-by":"publisher","first-page":"26447","DOI":"10.1074\/jbc.M109.003616","volume":"284","author":"L Zhang","year":"2009","unstructured":"Zhang L, Bowen T, Grennan-Jones F, Paddon C, Giles P, Webber J, et al. Thyrotropin receptor activation increases hyaluronan production in preadipocyte-fibroblasts; contributory role in hyaluronan accumulation in thyroid dysfunction. J Biol Chem. 2009;284:26447\u201355.","journal-title":"J Biol Chem"},{"key":"731_CR31","doi-asserted-by":"publisher","unstructured":"Hagood JS. Thy-1 as an integrator of diverse extracellular signals. Front Cell Dev Biol. 2019. https:\/\/doi.org\/10.3389\/fcell.2019.00026.","DOI":"10.3389\/fcell.2019.00026"},{"key":"731_CR32","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/S0002-9440(10)63488-8","volume":"163","author":"L Koumas","year":"2003","unstructured":"Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol. 2003 ;163:1291\u2013300.","journal-title":"Am J Pathol"},{"key":"731_CR33","doi-asserted-by":"publisher","unstructured":"Hu P, Barker TH. Thy-1 in integrin mediated mechanotransduction front. Cell Dev Biol. 2019. https:\/\/doi.org\/10.3389\/fcell.2019.00022.","DOI":"10.3389\/fcell.2019.00022"},{"issue":"4","key":"731_CR34","doi-asserted-by":"publisher","first-page":"e95586","DOI":"10.1371\/journal.pone.0095586","volume":"9","author":"He Li","year":"2014","unstructured":"Li H, Fitchett C, Kozdon K, Jayaram H, Rose GE, Bailly M, et al. Independent adipogenic and contractile properties of fibroblasts in Graves\u2019 orbitopathy: an in vitro model for the evaluation of treatments. PLoS ONE. 2014;9:e95586. https:\/\/doi.org\/10.1371\/journal.pone.0095586.","journal-title":"PLoS ONE"},{"key":"731_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46075-1.","volume":"9","author":"IH Yang","year":"2019","unstructured":"Yang IH, Rose GE, Ezra DG, Bailly M. Macrophages promote a profibrotic phenotype in orbital fibroblasts through increased hyaluronic acid production and cell contractility. Sci Rep. 2019;9:9622 https:\/\/doi.org\/10.1038\/s41598-019-46075-1.","journal-title":"Sci Rep."},{"issue":"5","key":"731_CR36","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/BOR.0b013e328349a255","volume":"23","author":"Min S. Shin","year":"2011","unstructured":"Shin MS, Lee N, Kang I. Effector T cell subsets in systemic lupus erythematosus: update focusing on Th17 cells. Curr Opin Rheumatol. 2011;23:444\u20138. https:\/\/doi.org\/10.1097\/BOR.0b013e328349a255.","journal-title":"Current Opinion in Rheumatology"},{"issue":"8","key":"731_CR37","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1210\/jc.2016-1882","volume":"101","author":"Sijie Fang","year":"2016","unstructured":"Fang S, Huang Y, Wang S, Zhang Y, Luo X, Liu L, et al. IL-17A exacerbates fibrosis by promoting the proinflammatory and profibrotic function of orbital fibroblasts in TAO. J Clin Endocrinol Metab. 2016;101:jc.2016-1882.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"731_CR38","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1210\/jc.2017-01349.","volume":"102","author":"S Fang","year":"2017","unstructured":"Fang S, Huang Y, Zhong S, Li Y, Zhang Y, Li Y, et al. Regulation of orbital fibrosis and adipogenesis by pathogenic Th17 cells in Graves orbitopathy. J Clin Endocrinol Metab. 2017;102:4273\u201383. https:\/\/doi.org\/10.1210\/jc.2017-01349.","journal-title":"J Clin Endocrinol Metab"},{"key":"731_CR39","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/ijms19030730.","volume":"19","author":"GR Lee","year":"2018","unstructured":"Lee GR. The balance of Th17 versus treg cells in autoimmunity. Int J Mol Sci. 2018;19:730. https:\/\/doi.org\/10.3390\/ijms19030730.","journal-title":"Int J Mol Sci"},{"key":"731_CR40","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1172\/JCI14235.","volume":"108","author":"KW Wucherpfennig","year":"2001","unstructured":"Wucherpfennig KW. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Investig. 2001;108:1097\u2013104. https:\/\/doi.org\/10.1172\/JCI14235.","journal-title":"J Clin Investig"},{"key":"731_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clim.2017.07.001","volume":"183","author":"H K\u00f6hling","year":"2017","unstructured":"K\u00f6hling H, Plummer SF, Marchesi JR, Davidge KS, Ludgate M. The microbiota and autoimmunity: their role in thyroid autoimmune diseases. Clin Immunol. 2017;183:63\u201374. https:\/\/doi.org\/10.1016\/j.clim.2017.07.001.","journal-title":"Clin Immunol"},{"issue":"6","key":"731_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40618-016-0594-6","volume":"40","author":"D. Covelli","year":"2017","unstructured":"Covelli D, Ludgate M. The thyroid, the eyes and the gut: a possible connection. J Endocrinol Investig. 2017. https:\/\/doi.org\/10.1007\/s40618-016-0594-6.","journal-title":"Journal of Endocrinological Investigation"},{"key":"731_CR43","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.4049\/jimmunol.162.8.4966","volume":"162","author":"M-C Many","year":"1999","unstructured":"Many M-C, Costagliola S, Detrait M, Denef J-F, Vassart G, Ludgate M. Development of an animal model of autoimmune thyroid eye disease. J Immunol. 1999;162:4966\u201374.","journal-title":"J Immunol"},{"key":"731_CR44","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1210\/en.2004-1015","volume":"146","author":"G Baker","year":"2005","unstructured":"Baker G, Mazziotti G, von Ruhland C, Ludgate M. Re-evaluating thyrotropin receptor induced mouse models of Graves\u2019 disease & ophthalmopathy. Endocrinology. 2005;146:835\u201344.","journal-title":"Endocrinology"},{"key":"731_CR45","doi-asserted-by":"publisher","unstructured":"Masetti G, Moshkelgosha S, K\u00f6hling H-L, Covelli D, Banga JP, Berchner-Pfannschmidt U, et al. Gut microbiota in experimental murine model of Graves\u2019 orbitopathy established in different environments may modulate clinical presentation of disease. Microbiome. 2018;6:97. https:\/\/doi.org\/10.1186\/s40168-018-0478-4; https:\/\/microbiomejournal.biomedcentral.com\/track\/pdf\/10.1186\/s40168-018-0478-4.","DOI":"10.1186\/s40168-018-0478-4"},{"key":"731_CR46","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hep4.1331","volume":"3","author":"N Ohtani","year":"2019","unstructured":"Ohtani N, Kawada N. Role of the gut\u2013liver axis in liver inflammation, fibrosis, and cancer: a special focus on the gut microbiota relationship. Hepatol Commun. 2019;3:456\u201370. https:\/\/doi.org\/10.1002\/hep4.1331.","journal-title":"Hepatol Commun"},{"issue":"5","key":"731_CR47","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00203-018-1506-2","volume":"200","author":"Ziv Savin","year":"2018","unstructured":"Savin Z, Kivity S, Yonath H, Yehuda S. Smoking and the intestinal microbiome. Arch Microbiol. 2018;200:677\u201384.","journal-title":"Archives of Microbiology"},{"key":"731_CR48","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/labinvest.2016.145","volume":"97","author":"X Liu","year":"2017","unstructured":"Liu X, Wong SS, Taype CA, Kim J, Shentu TP, Espinoza CR, et al. Thy-1 interaction with Fas in lipid rafts regulates fibroblast apoptosis and lung injury resolution. Lab Investig. 2017;97:256\u201367.","journal-title":"Lab Investig"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0731-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0731-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0731-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T22:59:48Z","timestamp":1695509988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-019-0731-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,16]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["731"],"URL":"https:\/\/doi.org\/10.1038\/s41433-019-0731-5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,16]]},"assertion":[{"value":"21 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}